XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Consolidated Statements of Shareholders' Equity and Redeemable Noncontrolling Interest - USD ($)
$ in Thousands
Redeemable Noncontrolling Interest [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
(Accumulated Deficit) / Retained Earnings [Member]
Noncontrolling Interests [Member]
Total
Beginning balance at Mar. 31, 2022 $ 22,491            
Ending balance at Jun. 30, 2022 22,491            
Beginning balance at Mar. 31, 2022   $ 0 $ 4,421,614 $ (946) $ (2,763,724) $ 381,999 $ 2,038,943
Beginning balance (in shares) at Mar. 31, 2022   694,975,965          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of the Company's common shares in connection with equity incentive plans and tax withholding payments   $ 0 (8,329) 0 0 0 (8,329)
Issuance of the Company's common shares in connection with equity incentive plans and tax withholding payments (in shares)   4,739,781          
Issuance of subsidiary common shares to the Company   $ 0 (251) 0 0 251 0
Issuance of subsidiary common shares to the Company (in shares)   0          
Issuance of the Company's common shares related to settlement of transaction consideration   $ 0 0 0 0 0 0
Issuance of the Company's common shares related to settlement of transaction consideration (in shares)   1,455,719          
Share-based compensation   $ 0 61,590 0 0 11,204 72,794
Foreign currency translation adjustment   0 0 5,966 0 (199) 5,767
Net income (loss)   0 0 0 (331,809) (21,975) (353,784)
Ending balance at Jun. 30, 2022   $ 0 4,474,624 5,020 (3,095,533) 371,280 1,755,391
Ending balance (in shares) at Jun. 30, 2022   701,171,465          
Beginning balance at Mar. 31, 2022 22,491            
Ending balance at Dec. 31, 2022 0            
Beginning balance at Mar. 31, 2022   $ 0 4,421,614 (946) (2,763,724) 381,999 2,038,943
Beginning balance (in shares) at Mar. 31, 2022   694,975,965          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss)             (1,054,601)
Ending balance at Dec. 31, 2022   $ 0 4,695,386 (729) (3,739,137) 471,618 1,427,138
Ending balance (in shares) at Dec. 31, 2022   726,804,831          
Beginning balance at Jun. 30, 2022 22,491            
Increase (Decrease) in Temporary Equity [Roll Forward]              
Deconsolidation of subsidiaries (22,491)            
Ending balance at Sep. 30, 2022 0            
Beginning balance at Jun. 30, 2022   $ 0 4,474,624 5,020 (3,095,533) 371,280 1,755,391
Beginning balance (in shares) at Jun. 30, 2022   701,171,465          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Deconsolidation of subsidiary   $ 0 0 0 0 0 0
Issuance of the Company's common shares in connection with equity incentive plans   $ 0 0 0 0 0 0
Issuance of the Company's common shares in connection with equity incentive plans (in shares)   1,185,639          
Issuance of the Company's common shares and other consideration for an acquisition   $ 0 8,836 0 0 112 8,948
Issuance of the Company's common shares and other consideration for an acquisition (in shares)   2,029,877          
Issuance of subsidiary common shares to the Company and cash contributions to majority-owned subsidiaries   $ 0 (2,240) 0 0 2,240 0
Share-based compensation   0 57,415 0 0 4,564 61,979
Foreign currency translation adjustment   0 0 4,069 0 (317) 3,752
Net income (loss)   0 0 0 (291,590) (24,331) (315,921)
Ending balance at Sep. 30, 2022   $ 0 4,538,635 9,089 (3,387,123) 353,548 1,514,149
Ending balance (in shares) at Sep. 30, 2022   704,386,981          
Ending balance at Dec. 31, 2022 $ 0            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of the Company's common shares, net of issuance costs   $ 0 94,735 0 0 0 94,735
Issuance of the Company's common shares, net of issuance costs (in shares)   20,000,000          
Issuance of the Company's common shares in connection with equity incentive plans and tax withholding payments   $ 0 (982) 0 0 0 (982)
Issuance of the Company's common shares in connection with equity incentive plans and tax withholding payments (in shares)   2,417,850          
Issuance of subsidiary common shares to the Company   $ 0 19,599 0 0 48,129 67,728
Deconsolidation of subsidiary   0 0 0 0 (292) (292)
Subsidiary stock options exercised   0 260 0 0 177 437
Issuance of subsidiary common shares to the Company and cash contributions to majority-owned subsidiaries   0 (2,822) 0 0 2,822 0
Share-based compensation   0 45,961 0 0 11,770 57,731
Issuance of subsidiary preferred shares   0 0 0 0 87,500 87,500
Foreign currency translation adjustment   0 0 (9,818) 0 846 (8,972)
Net income (loss)   0 0 0 (352,014) (32,882) (384,896)
Ending balance at Dec. 31, 2022   $ 0 4,695,386 (729) (3,739,137) 471,618 1,427,138
Ending balance (in shares) at Dec. 31, 2022   726,804,831          
Beginning balance at Mar. 31, 2023   $ 0 4,933,137 (2,617) (3,772,754) 449,821 1,607,587
Beginning balance (in shares) at Mar. 31, 2023   760,143,393          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of the Company's common shares in connection with equity incentive plans and tax withholding payments   $ 0 14,395 0 0 0 14,395
Issuance of the Company's common shares in connection with equity incentive plans and tax withholding payments (in shares)   6,994,468          
Subsidiary stock options exercised   $ 0 503 0 0 387 890
Share-based compensation   0 34,498 0 0 14,762 49,260
Cash contributions to majority-owned subsidiaries   0 (623) 0 0 623 0
Dividend declared by subsidiary   0 0 0 0 (6,000) (6,000)
Foreign currency translation adjustment   0 0 (3,993) 0 (155) (4,148)
Net income (loss)   0 0 0 (291,816) (36,029) (327,845)
Ending balance at Jun. 30, 2023   $ 0 4,981,910 (6,610) (4,064,570) 423,409 1,334,139
Ending balance (in shares) at Jun. 30, 2023   767,137,861          
Beginning balance at Mar. 31, 2023   $ 0 4,933,137 (2,617) (3,772,754) 449,821 1,607,587
Beginning balance (in shares) at Mar. 31, 2023   760,143,393          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss)             4,413,702
Ending balance at Dec. 31, 2023   $ 0 5,390,260 (27,784) 727,287 494,819 6,584,582
Ending balance (in shares) at Dec. 31, 2023   804,890,910          
Beginning balance at Jun. 30, 2023   $ 0 4,981,910 (6,610) (4,064,570) 423,409 1,334,139
Beginning balance (in shares) at Jun. 30, 2023   767,137,861          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of the Company's common shares, net of issuance costs   $ 0 199,822 0 0 0 199,822
Issuance of the Company's common shares, net of issuance costs (in shares)   19,600,685          
Issuance of the Company's common shares in connection with equity incentive plans, net of forfeitures, and tax withholding payments   $ 0 20,873 0 0 0 20,873
Issuance of the Company's common shares in connection with equity incentive plans, net of forfeitures, and tax withholding payments (in shares)   6,402,885          
Issuance of the Company's common shares related to settlement of warrants   $ 0 83,264 0 0 0 83,264
Issuance of the Company's common shares related to settlement of warrants (in shares)   7,554,549          
Issuance of the Company's common shares under employee stock purchase plan   $ 0 587 0 0 0 587
Issuance of the Company's common shares under employee stock purchase plan (in shares)   96,385          
Deconsolidation of subsidiary   $ 0 0 0 0 (35,050) (35,050)
Subsidiary stock options exercised   0 131 0 0 65 196
Share-based compensation   0 34,487 0 0 14,831 49,318
Cash contributions to majority-owned subsidiaries   0 (571) 0 0 571 0
Foreign currency translation adjustment   0 0 3,538 0 64 3,602
Net income (loss)   0 0 0 (304,327) (26,791) (331,118)
Ending balance at Sep. 30, 2023   $ 0 5,320,503 (3,072) (4,368,897) 377,099 1,325,633
Ending balance (in shares) at Sep. 30, 2023   800,792,365          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Disposition of Telavant   $ 0 0 0 0 (87,500) (87,500)
Issuance of the Company's common shares in connection with equity incentive plans and tax withholding payments   $ 0 2,456 0 0 0 2,456
Issuance of the Company's common shares in connection with equity incentive plans and tax withholding payments (in shares)   4,098,545          
Issuance of subsidiary common shares to the Company   $ 0 129,763 0 0 108,970 238,733
Issuance of subsidiary common shares to the Company (in shares)   0          
Subsidiary stock options exercised   $ 0 1,711 0 0 1,400 3,111
Issuance of subsidiary common shares to the Company and cash contributions to majority-owned subsidiaries   0 (104,172) 0 0 104,172 0
Share-based compensation   0 39,999 0 0 14,551 54,550
Foreign currency translation adjustment   0 0 (24,712) 0 (354) (25,066)
Net income (loss)   0 0 0 5,096,184 (23,519) 5,072,665
Ending balance at Dec. 31, 2023   $ 0 $ 5,390,260 $ (27,784) $ 727,287 $ 494,819 $ 6,584,582
Ending balance (in shares) at Dec. 31, 2023   804,890,910